The Law Offices of Frank R. Cruz reminds investors of upcoming deadlines to file lead plaintiff motions in class action lawsuits against PayPal, NuScale Power, and Corcept Therapeutics. These lawsuits allege the companies made false or misleading statements and failed to disclose material adverse facts affecting their business and prospects. PayPal is accused of overstating its business execution and dismissing competition concerns. NuScale is charged with misrepresenting the experience of its commercialization partner, exposing it to risks. Corcept is alleged to have hidden FDA concerns about its drug trial program. Investors who suffered losses during the specified class periods are encouraged to consider legal action before the April 20-21, 2026 deadlines.
Stripe and Advent International have jointly proposed to acquire PayPal in a deal valued at over $53 billion, offering $60.50 per share, a 28% premium over the previous close. The proposal, backed by $50 billion in financing, aims to combine PayPal's...
PayPal (PYPL) is rated a Strong Buy due to its undervalued stock price and strong financials, including $6.98 billion in cash and solid Q1 growth with 11% TPV and 25% adjusted free cash flow increases. The recent $53 billion buyout offer from Stripe ...
Payments company Stripe and private equity firm Advent International jointly offered to acquire PayPal for $60.50 per share, valuing the company at over $53 billion, a 28% premium to its recent closing price. The offer, backed by about $50 billion in...
PayPal's stock surged 16% in pre-market trading following reports that Stripe and Advent International made a $53 billion joint takeover offer. The bid values PayPal at $60.50 per share, a 28% premium over its recent closing price, and is backed by $...
